The Society
More than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS community
Become an ERS member
Consorcio Centro de Investigación Biomédica en Red MP (CIBER) is a Public Research Consortium created in 2006 under the leadership of the Carlos III Health Institute (ISCIII, the main Public Research Entity responsible of funding, managing and carrying out biomedical research in Spain), to promote research excellence and build a critical mass of researchers in the field of Biomedicine and Health Sciences. Organized in 11 research areas: Cardiovascular Diseases , Bioengineering, Biomaterials and Nanomedicine, Mental Health , Hepatic Diseases, Diabetes and Metabolic Diseases, Rare Diseases , Respiratory Diseases, Public Health and Epidemiology, Obesity and Nutrition; Fragility and Ageing.
Asthma\Biomarkers\COPD
Global fellowships (return phase only)\ European fellowships
CIBERES is the devoted area of CIBER to respiratory diseases including a Chronic Obstructive Pulmonary Disease research devoted to the study of COPD. The researchers investigate the molecular basis and phenotypic expression of the disease, look for specific biomarkers to characterize the disease, and investigate understand whether specific aspects of the lung microbiome relate to disease manifestations. CIBERES has specific cohorts: BioMPOC Spanish cohort of severe COPD (n=150). With data on sputum microbiome, transcriptomics, metabolomics and systemic biomarkers. Early-COPD cohort of n=300 individuals. CIBERES Biobank (http://biobancopulmonar.ciberes.org) with >60000 samples from >2000 patients, including lung and blood.
Despite their devoted annual budget provided by the Spanish goverment (equivalent to 2.75 Million euros ) the host counts more than 950k Euros of competitive European grants and more than 3,6M Euros obtained thorugh contract, grants and agreements devoted exclusively to studies in respiratory field.
One of the main missions of the CIBER is the translation of knowledge, so that the results of research that we generate are developed in protocols, services and products for the improvement of clinical practice and people’s quality of life. Thus, CIBER collaborate with industry and other private institutions under different types of agreements (license, R&D contract, Material Transfer Agreements, etc).
Setting up companies for technological development of research results from public institutions is one of the most widely-used strategies for transfer of knowledge. As well as providing the system with new services and products, quality employment is generated.
Since the date of its creation as a legal entity (2014) CIBER has participated in 6 different training programs. Currently finalized the MSCA ITN-NET in the areas of imaging and respiratory diseases and the FP7-People Co-funding DIATRAIN with two different mobility programs to promote secondments of national and international researchers. As an entity, CIBER is currently participating in the following training actions: Maratone, an MSCA ITN and M+VISIO an MSCA, COFUND project and the ITN Inspire Med.
No